BioTech Medics, Inc.
BMCS
Other OTC0.00
USD
- -
- -
CIK
0001384066
ISIN
US0906993078
CUSIP
090699307
Return %
Stock
S&P500
1Y
-98.55
18.86
3Y
-98.24
64.57
5Y
-99.69
71.65
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- CEO
- Anthony Keith Miller
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Address
- PO Box 93476 Southlake CA United States of America 76092-0114
- IPO Date
- Jul 23, 2010
- CIK
- 0001384066
- Website
- biotecmedics.com
- Similar Companies
- Business
- BioTech Medics, Inc. (BMCS) operates as a medical-based holding company focused on healthcare services, nutraceuticals, antimicrobial products, and commodity trading. The company provides medical therapeutic laser centers treating pain ailments affecting muscles, nerves, bones, and arthritis; SHBAN, an antiseptic hand and body sanitizer; nutraceutical products including BioBody Balance, a liquid vitamin concentrate, and BioBody Energy Spray, a caffeine- and alcohol-free natural vitamin energy spray sold through retail channels; and commodities such as calcium carbonate mined from its Dominican Republic operations, silica, carbon credits, and the Commodity Vault blockchain-based payment ecosystem for global product transactions. It serves healthcare providers, consumers, and commodity marketplaces, with laser centers in Texas, California, New Mexico, and Florida, and commodity activities spanning worldwide markets. Founded in 1997 and headquartered in Southlake, Texas as a Wyoming-incorporated entity trading on OTC Markets, BioTech Medics maintains operations primarily in the United States with international extensions in the Dominican Republic. In recent developments, the company has shifted strategically back to biotech roots while expanding into commodities, acquiring organic calcium assets and agreements with Dominican Republic holders for calcium carbonate reserves; it continues executing calcium business plans, including mining and global marketing of calcium, calcium carbonate, and silica through strategic alliances with biotech leaders for distribution, sales, and partnerships; additionally, it launched a YouTube channel and CEO interview in 2024 to enhance visibility.
Artelo Biosciences Presents ART26.12 Human Metabolite Data Demonstrating Favorable Drug Metabolism Characteristics Associated with Clinical Development Success
BioTech Medics-OTC CEO Interview and the Company Launches Its YouTube Channel
Bmcs Introduces You to Its Commodity Vault Website and Commodity Vault App
BioTech Medics Continues to Execute Its Calcium Business Plans
Biotech Medics has Acquired Organic Calcium Assets
BioTech Medics Launches Its Website and Plans to Move to The Next Tier
BioTech Medics, Inc. has Acquired Sumcoin Currency to Increase its Market Capitalization
Biotech Medics, Inc. Now Operating Sumcoin Nodes Directly